|
|
| Product Name: | CEF27 | | Synonyms: | RVRAYTYSK;CEF27;EPSTEIN-BARR VIRUS BRLF-1 LYTIC (148-156);H-ARG-VAL-ARG-ALA-TYR-THR-TYR-SER-LYS-OH;CEF27, Epstein-Barr Virus BRLF-1 lytic (148-156);L-Lysine, L-arginyl-L-valyl-L-arginyl-L-alanyl-L-tyrosyl-L-threonyl-L-tyrosyl-L-seryl-;CEF27, Epstein-Barr Virus BRLF-1 lytic 148-156 acetate;Epstein-Barr Virus BRLF-1 lytic 148-156 acetate(254110-79-7 free base) | | CAS: | 254110-79-7 | | MF: | C51H82N16O14 | | MW: | 1143.3 | | EINECS: | | | Product Categories: | peptide | | Mol File: | Mol File |  |
| | CEF27 Chemical Properties |
| Sequence | Arg-Val-Arg-Ala-Tyr-Thr-Tyr-Ser-Lys |
| | CEF27 Usage And Synthesis |
| Uses | CEF27, Epstein-Barr Virus BRLF-1 lytic 148-156 corresponding to amino acids 148-156 of the BRLF1 protein. BRLF1 is a transcriptional activator that binds directly to a GC-rich motif present in some Epstein-Barr virus (EBV) lytic gene promoters[1]. | | References | [1] Darr CD, et al. Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation. J Virol. 2001 Jul;75(13):6135-42. DOI:10.1128/JVI.75.13.6135-6142.2001 |
| | CEF27 Preparation Products And Raw materials |
|